Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For kidney transplant recipients:
- People with end-stage chronic kidney disease who are waiting to receive a kidney from a living donor
- Adults (18 years or older)
- People who have signed a consent form agreeing to take part
- Women of childbearing age who are using an effective method of contraception
- People who are covered by social security or an equivalent scheme
For living kidney donors:
- People who have been assessed as suitable to donate a kidney, with kidney filtration function above a certain level (confirm with trial site)
- Adults (18 years or older)
- People who have signed a consent form agreeing to take part
- Women of childbearing age who are using an effective method of contraception
- People who are covered by social security or an equivalent scheme
Who may not be able to join:
For both recipients and donors:
- People who cannot have an MRI scan — for example, due to severe claustrophobia, a pacemaker, an implantable heart device, or a non-MRI-compatible mechanical heart valve
- People who weigh more than 130 kg
- People who are pregnant, recently given birth, or currently breastfeeding
- People who are under a court or government order restricting their freedom
- Adults who are under a legal protection arrangement such as guardianship or curatorship
- People who are currently taking part in another research study that has an exclusion period which has not yet ended
For kidney transplant recipients only:
- People for whom a kidney biopsy would not be safe — for example, those on blood-thinning or anti-clotting medications that cannot be stopped, or those with certain blood count levels that are too low (confirm specific thresholds with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sandrine LEMOINE, PU-PH, Service de néphrologie à l'Hôpital Edouard Herriot
Phone: 04 72 11 02 44
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Apparent diffusion coefficient (ADC) coefficient values measured in diffusion-weighted MRI sequence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.